{"SPADE_N_14836": {"Sequence Information": {"Peptide Name": "Brevinin-1H", "Sequence": "FALGAVTKVLPKLFCLITRKC", "Sequence Length": 21, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Amolops hainanensis", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues.", "Pubmed ID": "32812694", "Reference": "Chem Biol Drug Des. 2020;:", "Author": "Pei X, Gong Z, Wu Q, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32812694"}], "Mass": 2321.93, "PI": 9.85, "Net Charge": 4, "Hydrophobicity": 1.08, "Frequent Amino Acids": "LKA", "Absent Amino Acids": "DEHMNOQSUWY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 13, "Polar Residues": 8, "Positive Residues": 4, "Negative Residues": 0, "SPADE ID": "SPADE_N_14836", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_15616", "Similarity": 1.0, "Sequence": "FALGAVTKVLPKLFCLITRKC"}, {"SPADE_ID": "SPADE_UN_15617", "Similarity": 1.0, "Sequence": "FALGAVTCLIRTKCKVLPKLF"}, {"SPADE_ID": "SPADE_UN_15618", "Similarity": 0.9523809523809523, "Sequence": "FALGAVTKVLYKLFCLITRKC"}], "Hemolytic Activity": "Horse erythrocytes:9.49% Hemolysis=4 µM,Horse erythrocytes:28% Hemolysis=32 µM,Horse erythrocytes:50% Hemolysis=53.12 µM", "Target Organism": "Staphylococcus aureus NCTC 10788(MIC=4µM),Staphylococcus aureus NCTC 10788(MBC=8µM),Escherichia coli NCTC 10418(MIC=16µM),Escherichia coli NCTC 10418(MBC=32µM),Candida albicans NCTC 1467(MIC=16µM),Candida albicans NCTC 1467(MFC=16µM),Pseudomonas aeruginosa ATCC 27853(MIC=64µM),Pseudomonas aeruginosa ATCC 27853(MBC=128µM),Staphylococcus aureus NCTC 12493(MIC=8µM),Staphylococcus aureus NCTC 12493(MBC=16µM),Klebsiella pneumoniae ATCC 43816(MIC=64µM),Klebsiella pneumoniae ATCC 43816(MBC=64µM),Human prostate adenocarcinoma PC-3(IC50=5.87µM),Human breast adenocarcinoma MDA-MB-435S(IC50=3.47µM),Human squamous lung carcinoma NCI-H157(IC50=3.37µM),Human colon adenocarcinoma HCT 116(IC50=2.599µM)"}}}